We are live on ! Find out more
FI

Fosun International Portfolio holdings

AUM $399M
1-Year Est. Return 16.11%
This Fund
S&P 500
This Quarter Est. Return
+4.57%
1 Year Est. Return
-16.11%
3 Year Est. Return
+16.92%
5 Year Est. Return
-0.68%
10 Year Est. Return
+98.52%
AUM
$1.96B
AUM Growth
+$368M
Cap. Flow
+$357M
Cap. Flow %
18.25%
Top 10 Hldgs %
57.7%
Holding
95
New
25
Increased
18
Reduced
8
Closed
8

Top Buys

Rank Stock Value
1
AMRX icon
Amneal Pharmaceuticals
AMRX
+$356M
2
AIFU
AIFU Inc
AIFU
+$72.5M
3
SINA
Sina Corp
SINA
+$48.9M
4
VIPS icon
Vipshop
VIPS
+$29.2M
5
DBRG icon
DigitalBridge
DBRG
+$25.4M

Sector Composition

Rank Sector Weight
1 Healthcare 35.43%
2 Financials 10.25%
3 Consumer Discretionary 6.8%
4 Communication Services 5.95%
5 Consumer Staples 1.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHEKW
76
DELISTED
Check-Cap Ltd. Series A Warrant
CHEKW
$30K ﹤0.01%
333,333
AAPL icon
77
Apple
AAPL
$4.95T
-20,000
Closed -$839K
BHC icon
78
Bausch Health
BHC
$1.67B
-1,740,258
Closed -$27.7M
CPRI icon
79
Capri Holdings
CPRI
$1.82B
-34,360
Closed -$2.13M
DIS icon
80
Walt Disney
DIS
$168B
-13,950
Closed -$1.4M
EEM icon
81
iShares MSCI Emerging Markets ETF
EEM
$28.6B
-2,324
Closed -$112K
F icon
82
Ford
F
$58.5B
-92,400
Closed -$1.02M
JNCE
83
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
-160,000
Closed -$3.58M
IPXL
84
DELISTED
Impax Laboratories, Inc.
IPXL
-3,854,995
Closed -$75M

Similar funds

Fosun International's Q2 2018 Portfolio in Review

As of Q2 2018, Fosun International held 95 positions worth $1.96B, up 23% from $1.59B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Fosun International deployed $357M of net new capital in Q2 2018, opening 25 new positions and adding to 18 existing holdings. Its largest new stake was Amneal Pharmaceuticals: 20,293,351 shares worth $333M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Hello Group, an estimated $124M trimmed.

  • Fosun International's largest Q2 2018 buy was Amneal Pharmaceuticals: 20,293,351 shares worth $333M.
  • Fosun International added most to AIFU Inc in Q2 2018, an estimated $72.5M increase.
  • Fosun International's biggest Q2 2018 reduction was Hello Group, cutting an estimated $124M.
  • Fosun International fully exited Impax Laboratories, Inc. in Q2 2018, selling an estimated $75M.
  • Fosun International's ten largest holdings make up 58% of its $1.96B portfolio in Q2 2018.
  • Fosun International opened 25 new positions and closed 8 in Q2 2018.
  • Fosun International's portfolio value rose 23% quarter-over-quarter to $1.96B.

Based on Fosun International's 13F filing for Q2 2018, filed 13 Aug 2018.